| Medical and Health Sciences | Lifetime | 571 | SE 7 | 99.97 |
| Oncology | Lifetime | 50 | SE 2 | 99.91 |
| Surgery | Lifetime | 271 | SE 7 | 99.77 |
| Pathology and Forensic Medicine | Lifetime | 227 | SE 3 | 99.16 |
| Pulmonary and Respiratory Medicine | Lifetime | 834 | SE 8 | 98.68 |
| Radiation Physics | Lifetime | 597 | SE 12 | 91.42 |
| Hepatology | Lifetime | 586 | SE 4 | 92.09 |
| Oncology | 2021-2025 | 188 | SE 1 | 98.53 |
| Surgery | 2021-2025 | 595 | SE 12 | 94.98 |
| Colorectal Cancer Surgical Treatments | Lifetime | 1 | SE 1 | 99.95 |
| Colorectal and Anal Carcinomas | Lifetime | 3 | SE 1 | 99.93 |
| Colorectal Cancer Treatments and Studies | Lifetime | 15 | SE 1 | 99.89 |
| Colorectal Cancer Screening and Detection | Lifetime | 21 | SE 1 | 99.81 |
| Gastric Cancer Management and Outcomes | Lifetime | 81 | SE 2 | 99.71 |
| Genetic factors in colorectal cancer | Lifetime | 75 | SE 2 | 99.61 |
| Advances in Oncology and Radiotherapy | Lifetime | 23 | SE 1 | 98.92 |
| Cancer Treatment and Pharmacology | Lifetime | 170 | SE 2 | 99.46 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 249 | SE 2 | 99.25 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 193 | SE 1 | 99.23 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 364 | SE 2 | 98.78 |
| Lymphoma Diagnosis and Treatment | Lifetime | 330 | SE 4 | 99.07 |
| Cancer survivorship and care | Lifetime | 213 | SE 1 | 98.41 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 665 | SE 16 | 98.34 |
| Cancer Genomics and Diagnostics | Lifetime | 953 | SE 16 | 98.34 |
| Multiple and Secondary Primary Cancers | Lifetime | 233 | SE 11 | 97.53 |
| Anorectal Disease Treatments and Outcomes | Lifetime | 218 | SE 8 | 97.78 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 642 | SE 2 | 97.60 |
| Advanced Radiotherapy Techniques | Lifetime | 813 | SE 15 | 97.44 |
| Palliative Care and End-of-Life Issues | Lifetime | 752 | SE 16 | 97.04 |
| Radiation Therapy and Dosimetry | Lifetime | 681 | SE 17 | 96.50 |
| Proteoglycans and glycosaminoglycans research | Lifetime | 430 | SE 24 | 96.03 |
| Viral-associated cancers and disorders | Lifetime | 775 | SE 19 | 96.35 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 455 | SE 7 | 94.83 |
| Diagnosis and treatment of tuberculosis | Lifetime | 568 | SE 8 | 93.70 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 705 | SE 10 | 92.48 |
| Colorectal Cancer Surgical Treatments | 2021-2025 | 21 | SE 1 | 99.11 |
| Colorectal and Anal Carcinomas | 2021-2025 | 21 | SE 1 | 98.73 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 77 | SE 1 | 98.12 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 129 | SE 1 | 98.22 |
| Genetic factors in colorectal cancer | 2021-2025 | 457 | SE 4 | 92.16 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 524 | SE 5 | 75.82 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 925 | SE 15 | 58.24 |
